Plasminogen Binding in Metastatic Breast Cancer Cells
Author Information
Author(s): M Ranson, NM Andronicos, MJ O'Mullane, MS Baker
Primary Institution: University of Wollongong
Hypothesis
The study aims to characterize the cell-surface plasminogen binding events in three human breast cancer cell lines.
Conclusion
The metastatic MDA-MB-231 cells have a significantly higher capacity to bind plasminogen compared to the non-metastatic MCF-7 and T-47D cells.
Supporting Evidence
- The MDA-MB-231 cells bound significantly more plasminogen than MCF-7 or T-47D cells.
- Non-viable cells bound two orders of magnitude more plasminogen than viable cells.
- Distinct plasminogen binding proteins were detected in the plasma membranes of the cell lines.
Takeaway
This study found that some breast cancer cells can grab onto a protein called plasminogen better than others, which might help them spread in the body.
Methodology
The study used dual-colour fluorescence flow cytometry, ligand histochemistry, and fluorimetry to analyze plasminogen binding in breast cancer cell lines.
Limitations
The presence of non-viable cells may affect the evaluation of authentic cell-surface plasminogen binding capacity.
Want to read the original?
Access the complete publication on the publisher's website